Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.370
+0.010 (0.74%)
At close: Sep 23, 2026, 4:00 PM EDT
1.390
+0.020 (1.46%)
Pre-market: Sep 24, 2026, 8:31 AM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $7.22 million as of September 23, 2026. Its market cap has increased by 15.94% in one year.
Market Cap
7.22M
Enterprise Value
-3.44M
1-Year Change
15.94%
Ranking
Category
Stock Price
$1.37
ChartMarket Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $7.22M, a decrease of -87.39%. That is a compound annual growth rate of -32.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 7.22M | 23.48% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evogene | 8.03M |
| Exicure | 7.99M |
| Longeveron | 7.95M |
| XTL Biopharmaceuticals | 7.87M |
| Traws Pharma | 7.82M |
| CNS Pharmaceuticals | 7.67M |
| Skye Bioscience | 7.66M |
| Enveric Biosciences | 6.85M |